We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EXLS:NASDAQExlService Holdings, Inc. Analysis

Data as of 2026-05-20 - not real-time

$28.97

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

ExlService delivered an earnings surprise of +8.6% and revenue growth of 13.8% YoY in Q1 2026, with adjusted EPS of $0.58 beating consensus estimates. Revenue now stands at $2.32 billion for the full year, close to analyst forecasts, and operating margins remain healthy at roughly 16%. The company’s cash position of $254 million exceeds its free cash flow generation, while debt-to-equity sits near 67%, reflecting a manageable leverage profile. Technical signals are mixed: the 20‑day SMA (≈30.2) and 50‑day SMA (≈30.4) sit above the current price of $28.97, and MACD is in a bearish crossover, yet the RSI of 42 suggests no immediate over‑sell. The DCF‑derived fair value of $42.66 implies a potential upside of over 40%, and the forward PE of 11.5 is well below the industry average of 38, underscoring significant valuation headroom. Market sentiment is extremely bullish (Fear & Greed Index 89), which may be pricing in optimism ahead of further AI‑driven growth.
Overall, the blend of strong top‑line momentum, attractive valuation metrics, and a stable, low‑beta profile positions EXLS as an appealing buy, while the bearish short‑term technical backdrop and moderate volatility advise a cautious, watchful stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Earnings beat and revenue acceleration
  • Current price below short‑term moving averages
  • Bearish MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF upside of >40% and forward PE advantage
  • Sustained revenue growth and expanding AI services
  • Stable cash flow and manageable debt levels

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong ROE (~28%) and high operating margins
  • Increasing demand for data and AI solutions across industries
  • Undervalued relative to industry peers with long‑run upside potential

Key Metrics & Analysis

Financial Health

Revenue Growth13.80%
Profit Margin11.66%
P/E Ratio18.5
ROE28.09%
ROA12.16%
Debt/Equity66.86
P/B Ratio5.7
Op. Cash Flow$349.2M
Free Cash Flow$295.1M
Industry P/E38.0

Technical Analysis

TrendBearish
RSI42.6
Support$26.82
Resistance$33.01
MA 20$30.21
MA 50$30.44
MA 200$37.66
MACDBearish
VolumeStable
Fear & Greed Index89.36

Valuation

Fair Value$42.66
Target Price$41.75
Upside/Downside44.11%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.56
Volatility39.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.